← Back
$IBRX All transactions

ImmunityBio, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

25,000

Price

$0

Filed

Jan 21

Insider

Name

Selecky Christobel

Title

CIK

0001849739

Roles

Director

Transaction Details

Transaction Date

2026-01-20

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

92,937

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025. | Represents the weighted average share price of an aggregate total of 25,000 shares sold in the price range of $7.50 to $7.52 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. | One hundred percent (100%) of the shares subject to the award vested on June 12, 2023, the date immediately preceding the 2023 annual meeting of stockholders.

Filing Info

Accession No.

0001849739-26-000002

Form Type

4

Issuer CIK

0001326110

Selecky Christobel's History

Date Ticker Type Value
2026-02-23 IBRX M $74K
2026-02-23 IBRX $250K
2026-02-23 IBRX M $0
2026-01-20 IBRX M $74K
2026-01-20 IBRX $188K
2026-01-20 IBRX M $0
2026-01-16 IBRX M $149K
2026-01-16 IBRX $250K
2026-01-16 IBRX M $0
2025-06-18 IBRX A $0

Other Insiders at IBRX (90d)

Insider Bought Sold Last
SOON-SHIONG PATRICK
See remarks
2026-03-31
LAUER REGAN J
Chief Accounting Officer
2026-02-22
Simon Barry J. $2.7M 2026-02-24
Adcock Richard
CEO & President
2026-02-22
Sachs David C.
Chief Financial Officer
2026-02-22
Selecky Christobel $250K 2026-02-23